PUMA BIOTECHNOLOGY, INC. (PBYI) ROI
- 2026-06-30: ROI 19.28%.
- 2026-03-31: ROI 17.45%.
- 2025-12-31: ROI 20.35%.
- 2025-09-30: ROI 24.82%.
Complete source-backed roi history.
- Available history
- 2020-09-30 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | 19.28% |
| 2026-03-31 | 17.45% |
| 2025-12-31 | 20.35% |
| 2025-09-30 | 24.82% |
| 2025-06-30 | 32.39% |
| 2025-03-31 | 24.87% |
| 2024-12-31 | 19.02% |
| 2024-09-30 | 15.58% |
| 2024-06-30 | 6.34% |
| 2024-03-31 | 10.18% |
| 2023-12-31 | 14.10% |
| 2023-09-30 | 2.69% |
| 2023-06-30 | -1.89% |
| 2022-12-31 | 0.00% |
| 2021-12-31 | -30.67% |
| 2021-09-30 | -56.18% |
| 2021-06-30 | -27.03% |
| 2021-03-31 | -22.97% |
| 2020-12-31 | -64.96% |
| 2020-09-30 | -57.95% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | 20.35% |
| 2024-12-31 | 19.02% |
| 2023-12-31 | 14.10% |
| 2022-12-31 | 0.00% |
| 2021-12-31 | -30.77% |
| 2020-12-31 | -64.96% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |